Media Coverage header image

Media Coverage

Advanced Search
  • 08132021
    The Body Pro

    The COVID-19 pandemic might have put a damper on testing for sexually transmitted infections (STIs)—in particular, chlamydia and gonorrhea—but not on the rate of infections, found an analysis published in May. The study, published in the American Journal of Preventive Medicine, concluded that stay-at-home orders early in the pandemic likely led to a 40% decrease in testing—though not necessarily in STI prevalence. “We’ve been losing the battle [against STIs] for six years, and COVID made it harder,” said Harvey W. Kaufman, M.D., senior medical director for Quest Diagnostics and an author of the study.

  • 08112021
    NPR TechNation Radio

    On this week’s Tech Nation, Moira speaks with DR. HARVEY KAUFMAN, the Senior Medical Director of Quest Diagnostics, about how the use or delay of medical tests reveals about the health status of the US.

  • 08062021
    Clinical Lab Products

    With the pandemic pressuring testing demand, lab stewardship programs can help with decision making and actionable insights to make the right testing decisions for patients, leading to better quality outcomes. By Lee Hilborne, MD, MPH.

  • 08062021
    Crain's New York Business

    Local health care providers and diagnostics companies are feeling the squeeze as demand increases for Covid-19 testing amid fears of the more-contagious Delta variant. The pattern has also affected companies that manufacture and process the tests, such as Quest Diagnostics. As of this week the Secaucus, N.J.–based company has performed 44.5 million tests since the beginning of the pandemic.

  • 07232021
    Real Simple

    If you're not sure what's causing your symptoms, you might want to start with an allergy test first. "When it comes to allergies, knowledge is power," says Jeffrey S. Dlott, MD, MS, senior medical director for Quest Diagnostics.

Show 5102550100 per page